Skip to main content
Log in

Avoid amputation if possible in patients with diabetic foot ulcers

  • Drugs Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ragnarson-Tennvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers. Pharmacoeconomics 1997 Jul; 12(1): 42–53

    Article  PubMed  CAS  Google Scholar 

  2. World Health Organization/IDF. Diabetes care and research in Europe: the St Vincent Declaration. Diabet Med 1990; 7: 360

    Article  Google Scholar 

  3. Apelqvist J, Ragnarson-Tennvall G, Persson U, et al. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463–71

    Article  PubMed  CAS  Google Scholar 

  4. Mackey WC, McCullough JL, Conlon TP, et al. The cost of surgery for limb-threatening ischemia. Surgery 1986; 99: 26–35

    PubMed  CAS  Google Scholar 

  5. Gupta SK, Veith FJ, Ascer E, et al. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis. Eur J Vasc Surg 1988; 2: 151–4

    Article  PubMed  CAS  Google Scholar 

  6. LoGerfo FW, Gibbons GW, Pomposelli Jr FB, et al. Trends in the care of diabetic foot: expanded role of arterial reconstruction. Arch Surg 1992; 127: 617–21

    Article  Google Scholar 

  7. Holstein P, Ellitsgaard N, Sørensen S, et al. The number of amputations has decreased [in Danish]. Nord Med 1996; 111(5): 142–4, 160

    PubMed  CAS  Google Scholar 

  8. Cheshire NJW, Noone MA, Wolfe JHN. Re-intervention after vascular surgery for critical leg ischaemia. Eur J Vasc Surg 1992; 6: 545–50

    Article  PubMed  CAS  Google Scholar 

  9. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995; 273: 712–20

    Article  PubMed  CAS  Google Scholar 

  10. Taylor Jr LM, Porter JM. The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987; 6: 454–9

    PubMed  Google Scholar 

  11. Apelqvist J, Ragnarson-Tennvall G, Larsson J. Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies. Diabet Med 1995; 12: 123–8

    Article  PubMed  CAS  Google Scholar 

  12. Apelqvist J, Ragnarson-Tennvall G. Cavity foot ulcers in diabetic patients — a comparative study of cadexomer iodine ointment and standard treatment: an economic analysis alongside a clinical trial. Acta Derm Venereol 1996; 76: 231–6

    PubMed  CAS  Google Scholar 

  13. Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986; New Series 60: 763–71

    PubMed  CAS  Google Scholar 

  14. Pieber TR, Holler A, Siebenhofer A, et al. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diab Med 1995; 12: 349–54

    Article  CAS  Google Scholar 

  15. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1993; 119: 36–41

    CAS  Google Scholar 

  16. Apelqvist J, Larsson J, Agardh C-D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485–91

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avoid amputation if possible in patients with diabetic foot ulcers. Drugs Ther. Perspect 11, 13–16 (1998). https://doi.org/10.2165/00042310-199811030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199811030-00005

Navigation